BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2449558)

  • 1. [The value of histochemical detection of prostate specific antigen].
    Hashimoto H; Yachiku S; Nishihara M; Arima S; Tokunaka S; Inada F
    Nihon Hinyokika Gakkai Zasshi; 1987 Aug; 78(8):1319-22. PubMed ID: 2449558
    [No Abstract]   [Full Text] [Related]  

  • 2. Epididymal metastasis from prostatic adenocarcinoma mimicking adenomatoid tumor.
    Rizk CC; Scholes J; Chen SK; Ward J; Romas NA
    Urology; 1990 Dec; 36(6):526-30. PubMed ID: 1701066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer-associated markers.
    Chu TM
    Immunol Ser; 1990; 53():339-56. PubMed ID: 1713065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uses and limitations of prostate-specific antigen in the laboratory diagnosis of prostate cancer.
    Wells DJ; Bennett BD; Gardner WA
    South Med J; 1988 Feb; 81(2):218-20. PubMed ID: 2448884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: Prostate specific antigen values after radical retropubic prostatectomy for adenocarcinoma of the prostate: impact of adjuvant treatment (hormonal and radiation).
    Fosså JD; Dearnaley DP
    J Urol; 1992 Jan; 147(1):173-4. PubMed ID: 1370328
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostate-specific antigen testing in untreated and treated prostatic adenocarcinoma.
    Rainwater LM; Morgan WR; Klee GG; Zincke H
    Mayo Clin Proc; 1990 Aug; 65(8):1118-26. PubMed ID: 1697014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate adenocarcinoma presenting with supraclavicular node enlargement: report of a case.
    Platania M; Bajetta E; Guadalupi V; Buzzoni R; Colecchia M
    Tumori; 2008; 94(5):769-71. PubMed ID: 19112959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crescentic glomerulonephritis associated with prostatic carcinoma: evidence of immune-mediated glomerular injury.
    Haskell LP; Fusco MJ; Wadler S; Sablay LB; Mennemeyer RP
    Am J Med; 1990 Feb; 88(2):189-92. PubMed ID: 1689105
    [No Abstract]   [Full Text] [Related]  

  • 9. Adenocarcinoma of the canine prostate: immunohistochemical examination for secretory antigens.
    McEntee M; Isaacs W; Smith C
    Prostate; 1987; 11(2):163-70. PubMed ID: 2444955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostatic specific antigen: immunoreactivity in urachal remnants.
    Golz R; Schubert GE
    J Urol; 1989 Jun; 141(6):1480-2. PubMed ID: 2470928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor associated glycoprotein-72 is highly expressed in prostatic adenocarcinomas.
    Myers RB; Meredith RF; Schlom J; LoBuglio AF; Bueschen AJ; Wheeler RH; Stockard CR; Grizzle WE
    J Urol; 1994 Jul; 152(1):243-6. PubMed ID: 8201675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy.
    Oesterling JE; Chan DW; Epstein JI; Kimball AW; Bruzek DJ; Rock RC; Brendler CB; Walsh PC
    J Urol; 1988 Apr; 139(4):766-72. PubMed ID: 2451037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostatic specific antigen.
    Shearer RJ
    Br J Urol; 1991 Jan; 67(1):1-5. PubMed ID: 1704275
    [No Abstract]   [Full Text] [Related]  

  • 14. Nuclear deoxyribonucleic acid ploidy and serum prostate specific antigen in operable prostatic adenocarcinoma.
    Nativ O; Myers RP; Farrow GM; Therneau TM; Zincke H; Lieber MM
    J Urol; 1990 Aug; 144(2 Pt 1):303-6. PubMed ID: 1695690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunohistochemical identification of specific prostatic phosphatases and specific prostatic antigen in prostatic tumors].
    Bonetti F; Pisa R; Chilosi M; Loddo G; Menestrina F; Zamboni G; Pea M
    Pathologica; 1983; 75(1040):789-95. PubMed ID: 6201809
    [No Abstract]   [Full Text] [Related]  

  • 16. HOXB13 as an immunohistochemical marker of prostatic origin in metastatic tumors.
    Barresi V; Ieni A; Cardia R; Licata L; Vitarelli E; Reggiani Bonetti L; Tuccari G
    APMIS; 2016 Mar; 124(3):188-93. PubMed ID: 26590121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prostate-specific antigen in the diagnosis of prostatic carcinoma].
    Virseda JA; Morente M; Piris MA; Melchor AM; Gil Pascual B; Gómez A
    Actas Urol Esp; 1985; 9(1):89-94. PubMed ID: 2409752
    [No Abstract]   [Full Text] [Related]  

  • 18. [The clinical evaluation of prostatic specific antigen in prostatic cancer].
    Hiromoto Y; Hiramori M; Higaki Y; Imammura K
    Nihon Hinyokika Gakkai Zasshi; 1988 Apr; 79(4):606-12. PubMed ID: 2465428
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunocytochemical localisation of prostate-specific antigen: specificity and application to clinical practice.
    Ford TF; Butcher DN; Masters JR; Parkinson MC
    Br J Urol; 1985 Feb; 57(1):50-5. PubMed ID: 2578846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prostate antigen as a tumor marker of prostate cancer. (1) Changes of prostate antigen values during anti-androgen therapy].
    Kuriyama M; Takeuchi T; Okano M; Fujimoto Y; Fujihiro S; Nishiura T; Murphy GP; Chu TM
    Nihon Gan Chiryo Gakkai Shi; 1984 Aug; 19(7):1481-7. PubMed ID: 6084037
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.